Common Toxicity Criteria Version 2.0 ...繼續閱讀

PERFORMANCE STATUS SCALES ...繼續閱讀

截瘤達併用新型標靶治療藥物治療轉移乳癌：理論依據與臨床試驗結果
Capecitabine in Combination with Novel Targeted Agents in the Management of Metastatic Breast Cancer: Underlying Rationale and Results of Clinical Trials
The Oncologist, Vol. 12, No. 4, 375-389, April 2007
...繼續閱讀

綠茶與乳癌之預防
Green tea and the prevention of breast cancer: a case-control study
Carcinogenesis 2007 28(5):1074-1078
（這是西澳大學與浙江大學合作的研究） ...繼續閱讀

使用紅血球生成素治療貧血之癌症病人
Results from a Phase III, randomized, double-blind, placebo-controlled study of darbepoetin alfa for the treatment of anemia in patients not receiving chemotherapy or radiotherapy

2007 AACR Annual Meeting ...繼續閱讀

併用聚乙烯二醇化的微脂體doxoubicin與健澤治療接受過化學治療的晚期乳癌病人：第二期試驗
Phase II trial of pegylated liposomal doxorubicin (Caelyx) plus Gemcitabine in chemotherapeutically pretreated patients with advanced breast cancer
Acta Oncologica, Volume 46,Issue 2 2007 , pages 208 - 213 ...繼續閱讀

紫杉醇的副作用
Managing taxane toxicities
Maurie Markman
Support Care Cancer (2003) 11:144–147 ...繼續閱讀

可能與癌症惡化有關的生長因子TGF-beta
April 6, 2007
http://www.mc.vanderbilt.edu/reporter/index.html?ID=5454 ...繼續閱讀

HER2 therapy. Small molecule HER-2 tyrosine kinase inhibitors
針對HER2的治療：小分子HER-2酪胺酸激脢抑制劑

Breast Cancer Research 2007, 9:205 ...繼續閱讀

Pazopanib：新的多種酪胺酸激脢抑制劑

Pazopanib: A Novel Multitargeted Tyrosine Kinase Inhibitor
Guru Sonpavde and Thomas E. Hutson
Current Oncology Reports 2007, 9:115-119 ...繼續閱讀

併用健澤與vinorelbine與單僅使用vinorelbine治療，對於接受過anthracycline類藥物與紫杉醇類藥物治療的轉移乳癌病人的效果

Gemcitabine plus vinorelbine versus vinorelbine monotherapy in patients with metastatic breast cancer previously treated with anthracyclines and taxanes: final results of the phase III Spanish Breast Cancer Research Group (GEICAM) trial

Volume 8, Issue 3 , March 2007, Pages 219-225 ...繼續閱讀

併用letrozole與Herceptin作為HER2陽性與雌激素受體陽性的晚期乳癌病人之第一線或第二線治療，病情可以達致相當期間的反應
The combination of letrozole and trastuzumab as first or second-line biological therapy produces durable responses in a subset of HER2 positive and ER positive advanced breast cancers
P. Kelly Marcom, Claudine Isaacs, Lyndsay Harris, Zee Wang Wong, Aruna Kommarreddy, Nellie Novielli, Gretchen Mann, Yu Tao and Matthew J. Ellis
Breast Cancer Research and Treatment Volume 102, Number 1 / March, 2007 Pages 43-49 ...繼續閱讀

Vinflunine：晚期乳癌之新的第二線治療藥物
Vinflunine: a new active drug for second-line treatment of advanced breast cancer. Results of a phase II and pharmacokinetic study in patients progressing after first-line anthracycline/taxane-based chemotherapy
British Journal of Cancer (2006) 95, 1161-1166. ...繼續閱讀

在經過多種治療的轉移乳癌病人併用健澤與oxaliplatin
Gemcitabine–Oxaliplatin Combination in Heavily Pretreated Metastatic Breast Cancer: A Pilot Study on 43 Patients
Volume 13 Issue 2 Page 165 - March/April 2007 ...繼續閱讀

Capecitabine
The Oncologist, Vol. 12, No. 2, 152-155, February 2007;
doi:10.1634/theoncologist.12-2-152
Schellens, J. H.M. ...繼續閱讀

1.
不管先前是否接受過雙磷酸鹽類藥物治療，ibandronate都可以減低病人的疼痛
[1076] Pain reduction with ibandronate is achieved regardless of prior bisphosphonate treatment.

2.
以15分或60分之時間經靜脈注射ibandronate對於腎臟的安全性
[1078] Renal safety of intravenous ibandronate 6mg infused over 15 or 60 minutes in patients with breast cancer and bone metastases. ...繼續閱讀

1.
併用Iressa與docetaxel治療轉移乳癌病人
[1093] A randomized phase II trial with gefitinib and docetaxel in metastatic breast cancer: an evaluation of the treatment regimen and the factors associated with toxicity.
2.
併用Avastin以及與白蛋白結合之紫杉醇（Abraxane）治療轉移乳癌病人
[1095] Bevacizumab (avastin) and albumin bound paclitaxel (abraxane) treatment in metastatic breast cancer. ...繼續閱讀

1.
以lapatinib作為罹患過度表現ErbB2之晚期或轉移乳癌併的第一線治療
[1090] Updated biomarker results from a phase II randomized study of lapatinib as first-line treatment for patients with ErbB2-amplified advanced or metastatic breast cancer.

2.
Lapatinib治療晚期或轉移乳癌病人的第二期試驗
[1091] Phase II clinical study of lapatinib (GW572016) in patients with advanced
or metastatic breast cancer. ...繼續閱讀

1.
併用截瘤達與Avastin作為轉移乳癌病人第一線治療
[2068] Capecitabine plus bevacizumab in first line metastatic breast cancer: an interim safety and efficacy report of the first phase of xeloda plus avastin 1st line metastatic breast cancer trial.
2.
使用正子造影掃描評估罹患HER2陽性之轉移乳癌病人以lapatinib治療的效果
[1089] Evaluation of response to lapatinib in patients with HER2-positive metastatic breast cancer using FDG-PET. ...繼續閱讀

1.
Herceptin 與 KOS-953治療Her2陽性乳癌病人
[1102] Phase 2 trial of trastuzumab (T) and KOS-953 (17-AAG) in patients with Her2-positive breast cancer: preliminary results.
2.
截瘤達與vinnorelbine在罹患轉移乳癌的老年病人作為第一線治療：第二期試驗
[6089] Capecitabine (C) and vinorelbine (V) in elderly patients (pts.) with metastatic breast cancer (MBC) as 1st line treatment: a prospective multicentre phase II study of the NOGGO breast cancer study group. ...繼續閱讀